The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act that passed in congress in 2020 extends Medicare coverage for anti-rejection drugs from 36 months to the life of the transplant. Troy Zimmerman, Special Projects Director, National Kidney Foundation worked closely with congress to bring this bill to fruition. He explains the details of the bill, when it goes into effect and who will benefit by the new law.